2022
DOI: 10.1016/j.ejmg.2022.104455
|View full text |Cite
|
Sign up to set email alerts
|

A recessive variant in SIM2 in a child with complex craniofacial anomalies and global developmental delay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…Mouse models have established that deletion of the Sim2 gene produces a variety of developmental phenotypes; however, the extent to which SIM2 gene variants cause or contribute to human pathologies remains undetermined. Recently a study proposed a homozygous SIM2 variant (p.Tyr154Cys) as the cause of the clinical presentation in a child with craniofacial abnormalities, developmental delay and intellectual disability [ 25 ]. Understanding the molecular basis of how non-synonymous nucleotide variants can alter the activity of SIM2 will not only provide a greater understanding of the way SIM2 functions as a transcription factor but could also highlight the possibility of these variants causing or contributing to human disease.…”
Section: Discussionmentioning
confidence: 99%
“…Mouse models have established that deletion of the Sim2 gene produces a variety of developmental phenotypes; however, the extent to which SIM2 gene variants cause or contribute to human pathologies remains undetermined. Recently a study proposed a homozygous SIM2 variant (p.Tyr154Cys) as the cause of the clinical presentation in a child with craniofacial abnormalities, developmental delay and intellectual disability [ 25 ]. Understanding the molecular basis of how non-synonymous nucleotide variants can alter the activity of SIM2 will not only provide a greater understanding of the way SIM2 functions as a transcription factor but could also highlight the possibility of these variants causing or contributing to human disease.…”
Section: Discussionmentioning
confidence: 99%
“…We first applied our optimized laboratory processing pipelines that look for recessive mutations (Al-Kurbi et al 2022) and structural variants (E Aliyev, A Visconti, N Syed, et al, unpubl.), but we did not find any candidate variants that could be linked to the presented disease phenotype. We then used a combinatorial approach for de novo mutation calling that leverages three separate underlying approaches to identify 92 high genotype quality de novo variants.…”
Section: Genomic Analysesmentioning
confidence: 99%